These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 21734183)

  • 21. Ambulatory capacity and disease progression as measured by the 6-minute-walk-distance in Duchenne muscular dystrophy subjects on daily corticosteroids.
    Goemans N; van den Hauwe M; Wilson R; van Impe A; Klingels K; Buyse G
    Neuromuscul Disord; 2013 Aug; 23(8):618-23. PubMed ID: 23770101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
    McDonald CM; Henricson EK; Han JJ; Abresch RT; Nicorici A; Elfring GL; Atkinson L; Reha A; Hirawat S; Miller LL
    Muscle Nerve; 2010 Apr; 41(4):500-10. PubMed ID: 19941337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moving towards meaningful measurement: Rasch analysis of the North Star Ambulatory Assessment in Duchenne muscular dystrophy.
    Mayhew A; Cano S; Scott E; Eagle M; Bushby K; Muntoni F;
    Dev Med Child Neurol; 2011 Jun; 53(6):535-42. PubMed ID: 21410696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal natural history in young boys with Duchenne muscular dystrophy.
    Coratti G; Brogna C; Norcia G; Ricotti V; Abbott L; D'Amico A; Berardinelli A; Vita GL; Lucibello S; Messina S; Sansone V; Albamonte E; Colia G; Salmin F; Gardani A; Manzur A; Main M; Baranello G; Arnoldi MT; Parsons J; Carry T; Connolly AM; Bertini E; Muntoni F; Pane M; Mercuri E
    Neuromuscul Disord; 2019 Nov; 29(11):857-862. PubMed ID: 31629611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the relationship between North Star Ambulatory Assessment and Health Utilities Index scores in Duchenne muscular dystrophy.
    Audhya I; Rogula B; Szabo SM; Feeny D; Bolatova T; Gooch K
    Health Qual Life Outcomes; 2023 Jul; 21(1):76. PubMed ID: 37468890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.
    Bello L; Piva L; Barp A; Taglia A; Picillo E; Vasco G; Pane M; Previtali SC; Torrente Y; Gazzerro E; Motta MC; Grieco GS; Napolitano S; Magri F; D'Amico A; Astrea G; Messina S; Sframeli M; Vita GL; Boffi P; Mongini T; Ferlini A; Gualandi F; Soraru' G; Ermani M; Vita G; Battini R; Bertini E; Comi GP; Berardinelli A; Minetti C; Bruno C; Mercuri E; Politano L; Angelini C; Hoffman EP; Pegoraro E
    Neurology; 2012 Jul; 79(2):159-62. PubMed ID: 22744661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid treatment and the development of scoliosis in males with duchenne muscular dystrophy.
    Alman BA; Raza SN; Biggar WD
    J Bone Joint Surg Am; 2004 Mar; 86(3):519-24. PubMed ID: 14996877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 6 Minute walk test in Duchenne MD patients with different mutations: 12 month changes.
    Pane M; Mazzone ES; Sormani MP; Messina S; Vita GL; Fanelli L; Berardinelli A; Torrente Y; D'Amico A; Lanzillotta V; Viggiano E; D'Ambrosio P; Cavallaro F; Frosini S; Bello L; Bonfiglio S; Scalise R; De Sanctis R; Rolle E; Bianco F; Van der Haawue M; Magri F; Palermo C; Rossi F; Donati MA; Alfonsi C; Sacchini M; Arnoldi MT; Baranello G; Mongini T; Pini A; Battini R; Pegoraro E; Previtali SC; Napolitano S; Bruno C; Politano L; Comi GP; Bertini E; Morandi L; Gualandi F; Ferlini A; Goemans N; Mercuri E
    PLoS One; 2014; 9(1):e83400. PubMed ID: 24421885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk Test.
    Hamuro L; Chan P; Tirucherai G; AbuTarif M
    CPT Pharmacometrics Syst Pharmacol; 2017 Sep; 6(9):596-603. PubMed ID: 28643370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association Between Physical Activity/Heart Rate Variability Data Obtained Using a Wearable Device and Timed Motor Functional Tests in Patients with Duchenne Muscular Dystrophy: A Pilot Study.
    Nakamura A; Matsumura T; Takeshima Y; Kuru S; Imazaki M; Nonomura H; Kaiya H
    J Neuromuscul Dis; 2024; 11(3):715-724. PubMed ID: 38607760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quadriceps muscle strength in Duchenne muscular dystrophy and effect of corticosteroid treatment.
    Merlini L; Cecconi I; Parmeggiani A; Cordelli DM; Dormi A
    Acta Myol; 2020 Dec; 39(4):200-206. PubMed ID: 33458575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy.
    Ayyar Gupta V; Pitchforth JM; Domingos J; Ridout D; Iodice M; Rye C; Chesshyre M; Wolfe A; Selby V; Mayhew A; Mazzone ES; Ricotti V; Hogrel JY; Niks EH; de Groot I; Servais L; Straub V; Mercuri E; Manzur AY; Muntoni F;
    PLoS One; 2023; 18(4):e0283669. PubMed ID: 37099511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy.
    Machado DL; Silva EC; Resende MB; Carvalho CR; Zanoteli E; Reed UC
    BMC Res Notes; 2012 Aug; 5():435. PubMed ID: 22889007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deflazacort versus prednisone/prednisolone for maintaining motor function and delaying loss of ambulation: A post HOC analysis from the ACT DMD trial.
    Shieh PB; Mcintosh J; Jin F; Souza M; Elfring G; Narayanan S; Trifillis P; Peltz SW; Mcdonald CM; Darras BT;
    Muscle Nerve; 2018 Nov; 58(5):639-645. PubMed ID: 30028519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy.
    Mercuri E; Signorovitch JE; Swallow E; Song J; Ward SJ; ;
    Neuromuscul Disord; 2016 Sep; 26(9):576-83. PubMed ID: 27423700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrical impedance myography in Duchenne muscular dystrophy and healthy controls: A multicenter study of reliability and validity.
    Zaidman CM; Wang LL; Connolly AM; Florence J; Wong BL; Parsons JA; Apkon S; Goyal N; Williams E; Escolar D; Rutkove SB; Bohorquez JL;
    Muscle Nerve; 2015 Oct; 52(4):592-7. PubMed ID: 25702806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.
    McDonald CM; Henricson EK; Abresch RT; Florence JM; Eagle M; Gappmaier E; Glanzman AM; ; Spiegel R; Barth J; Elfring G; Reha A; Peltz S
    Muscle Nerve; 2013 Sep; 48(3):343-56. PubMed ID: 23681930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy.
    Zamani G; Hosseinpour S; Ashrafi MR; Mohammadi M; Badv RS; Tavasoli AR; Akbari MG; Bereshneh AH; Malamiri RA; Heidari M
    BMC Neurol; 2022 May; 22(1):162. PubMed ID: 35501714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance.
    Oreto L; Vita GL; Mandraffino G; Carerj S; Calabrò MP; Manganaro R; Cusmà-Piccione M; Todaro MC; Sframeli M; Cinquegrani M; Toscano A; Vita G; Messina S; Zito C
    Acta Myol; 2020 Dec; 39(4):191-199. PubMed ID: 33458574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 6 minute walk test and performance of upper limb in ambulant duchenne muscular dystrophy boys.
    Pane M; Mazzone ES; Sivo S; Fanelli L; De Sanctis R; D'Amico A; Messina S; Battini R; Bianco F; Scutifero M; Petillo R; Frosini S; Scalise R; Vita GL; Bruno C; Pedemonte M; Mongini T; Pegoraro E; Brustia F; Gardani A; Berardinelli A; Lanzillotta V; Viggiano E; Cavallaro F; Sframeli M; Bello L; Barp A; Busato F; Bonfiglio S; Rolle E; Colia G; Bonetti A; Palermo C; Graziano A; D'Angelo G; Pini A; Corlatti A; Gorni K; Baranello G; Antonaci L; Bertini E; Politano L; Mercuri E
    PLoS Curr; 2014 Oct; 6():. PubMed ID: 25642376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.